【異動股】中國生物製藥(01177.HK)、信達生物(01801.HK)新藥有進展,升逾5% 2021-05-18T07:30:56-04:00May 18th, 2021| share this article! 【財華社訊】中國生物製藥(01177.HK)、信達生物(01801.HK)新藥研發有進展,股價均彈升逾5%。中國生物製藥於15:25揚升5.2%或0.44港元,報8.87港元,見2個月高位;成交金額11.16億港元。信達生物彈近5.5%或4.75港元,報91.8港元,見3個月高位;成交金額7.73億港元。 Read More share this article! Related Posts Japan, EU universities to partner on fostering chip and AI talent May 3rd, 2024 Vietnam’s Galaxy Education eyes up to $20m fundraising to expand footprint May 3rd, 2024 Sony looks to boost film assets with $26bn Paramount acquisition May 3rd, 2024 Soundwill pushes to revalue Causeway Bay site as demand declines May 3rd, 2024